Physician profile
Robert Alexander
NPI 1558330159
$1,928.67
in general payments reported to CMS, 2019-2025
8 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $135 · 2021: $327 · 2022: $107 · 2023: $417 · 2024: $366 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,138.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,655.33 | 2019-2025 | Mako, Tornier Perform Reversed Glenoid, Conextions Tr Tendon Repair System-Implant Mechanism |
| Bioventus LLC | $74.89 | 2022-2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Pacira Therapeutics, INC. | $63.71 | 2019-2021 | |
| Smith+Nephew, INC. | $52.14 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Sanofi-Aventis U.S. LLC | $33.78 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $16.62 | 2025 | |
| Convatec INC. | $16.40 | 2024 | |
| Depuy Synthes Sales INC. | $15.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.